The prevalence of multiple endocrine<unk> <unk> -1 (MEN-1) is approximately 2-3 per 100,000 individuals worldwide. Patients of all age groups may develop MEN-1, but it is commonly diagnosed among patients between 18-50 years of age. MEN-1 affects men and women equally. There is no racial predilection to MEN-1.
Multiple endocrine neoplasia type 1 epidemiology and demographics
Multiple endocrine neoplasia type 2 epidemiology and demographics
Multiple endocrine neoplasia type 1 classification
Multiple endocrine neoplasia type 1 pathophysiology
Multiple endocrine neoplasia type 2 pathophysiology
Alstrom syndrome epidemiology and demographics
Autoimmune polyendocrine syndrome epidemiology and demographics
Glucagonoma epidemiology and demographics